The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Encompass Health Corp shares valued at $14,387,152 were sold by Tarr Mark J on May 20 ’25. At $121.53 per share, Tarr Mark J sold 118,384 shares. The insider’s holdings dropped to 527,070 shares worth approximately $63.92 million following the completion of this transaction.
Also, Mark Tarr purchased 118,384 shares, netting a total of over 14,383,656 in proceeds.
Before that, Charbonneau Elissa Joy had sold 4,279 shares from its account. In a trade valued at $498,974, the Chief Medical Officer traded Encompass Health Corp shares for $116.61 each. Upon closing the transaction, the insider’s holdings decreased to 4,279 shares, worth approximately $1.45 million.
As published in their initiating research note from KeyBanc Capital Markets on October 11, 2024, Encompass Health Corp [EHC] has been an Overweight and the price target has been revised to $115. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in early July. As of March 06, 2024, Barclays has initiated its “an Overweight” rating for EHC. Earlier on March 14, 2023, Barclays initiated its rating. Their recommendation was “an Equal weight” for EHC stock.
Analyzing EHC Stock Performance
During the last five days, there has been a surge of approximately 1.46%. Over the course of the year, Encompass Health Corp shares have jumped approximately 31.32%. Shares of the company reached a 52-week high of $123.13 on 06/04/25 and a 52-week low of $87.85 on 01/03/25.
Support And Resistance Levels for Encompass Health Corp (EHC)
According to the 24-hour chart, there is a support level at 120.62, which, if violated, would cause prices to drop to 119.98. In the upper region, resistance lies at 122.52. The next price resistance is at 123.78. RSI (Relative Strength Index) is 65.42 on the 14-day chart, showing neutral technical sentiment.
